Decentralized Clinical Trials Are Closer Than You Think
By Jennifer Duff, General Manager, Zelta (by Merative)
![GettyImages-1278681737 decentralized trials GettyImages-1278681737 decentralized trials](https://vertassets.blob.core.windows.net/image/bcd02350/bcd02350-4913-4c7d-a519-11162bcbee57/375_250-gettyimages_1278681737_decentralized_trials.jpg)
A decentralized clinical trial (DCT) is a popular buzzword right now, but behind the buzz is the usual mix of noise and confusion. For example, a DCT doesn’t mean decentralizing everything. In fact, fully decentralized or virtual trials are relatively rare. Far more common is a hybrid approach that mixes elements of both on-site and remote capabilities. For example, a more realistic DCT study may feature electronic consent (e-consent), data collected directly from wearable devices, televisits and sample collection at a local pharmacy, while still requiring a portion of research data to be captured during specific visits to an investigator site.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.